Biktarvy Label Update Adds Data on Safety, Efficacy in Pregnant HIV Patients
The approval was based on data from an open-label clinical trial that included 33 virologically-suppressed pregnant adults.
Source: clinicaladvisor.com
Jared Baeten News Today : Breaking News, Live Updates & Top Stories | Vimarsana
Stay updated with breaking news from Jared Baeten. Get real-time updates on events, politics, business, and more. Visit us for reliable news and exclusive interviews.
Top News In Jared Baeten Today - Breaking & Trending Today
FDA approves Gilead Sciences' Biktarvy label update for pregnant adults with HIV
The updated label with additional data reinforces the safety and efficacy profile of Biktarvy to treat pregnant people with HIV-1 with suppressed viral loads, the company said.
Source: drugstorenews.com
Biktarvy Label Update Adds Data on Safety, Efficacy in Pregnant HIV Patients
The approval was based on data from an open-label clinical trial that included 33 virologically-suppressed pregnant adults.
Source: empr.com
FDA Approves Biktarvy Label Update With Data for Pregnant Adults With HIV
26.04.2024 - Gilead Sciences, Inc. (Nasdaq: GILD) today announced the U.S. Food and Drug Administration (FDA) approved an updated label with additional data reinforcing the safety and efficacy profile of Biktarvy (bictegravir 50 mg/emtricitabine 200 mg/tenofovir ... Seite 1
Source: wallstreet-online.de
Bictegravir Receives Expanded Indication by FDA to Treat HIV
Patients with HIV who have suppressed viral loads and pre-existing resistance will be able to use bictegravir with this FDA approval.
Source: ajmc.com